 Wysłany: Czw 15:37, 03 Mar 2011 Temat postu: Male patients with decompensated liver cirrhosis p |
|
| Male patients with decompensated liver cirrhosis pituitary and gonadal hormone levels
, LH few as E: / T increased and decreased,p90x workout calendar, most normal, but increased in some of this and testicular atrophy, estrogen increased and hypothalamic-pituitary-gonadal axis dysfunction ~ 【4 larvae dry shed for the BCG Ying News Jiapan centimes Efficacy of hepatitis B Lu Wang Xiuquan Hospital of Qingdao brittle state Qingdao hospital for infectious diseases control Syrian Gushi Ying Li Jinli / ~ r / z ~ such as port 'r l1 January 1989 ~ August 1991, we with BCG (BCG) Jiapan centimes treatment of 50 cases of hepatitis B patients, and achieved good effect. Now following results. First, the materials and methods (a) pot case selection: According to the National Viral Hepatitis Conference in 1984 established diagnostic criteria, select inpatient and outpatient 88 cases of hepatitis B patients. ① treatment group were randomly divided into: 50 cases,supra for sale, including chronic active hepatitis (CAH) 13 cases, slow moving liver (CPH) 22 cases, 15 cases of asymptomatic carriers, 38 male and female l2, age 8-58 years old average of 31.6 years,tory burch outlet, average duration of 1.87 years. ② control group: 38 cases, including cases of chronic active hepatitis l4, slow to move the liver in 14 cases, 10 cases of asymptomatic carriers,tory burch shoes, M 3O steel, guillotine and 8 females, aged 7 to 63 years, mean 30.9 years, average duration of 2 .1 years. The two groups in gender, age, disease type, disease, liver function and HBVM so, there are comparable. (  Treatment: chest made before inoculation Bc8, negative do l: 2000 (5IU) 0T test to observe 24,48,72.4 ~, the injection site, slight swelling, induration diameter of 0.05) . Jaundice, hepatosplenomegaly and other signs of significant improvement, compared with the control group but no significant (P> 0.05). ( Laboratory tests: i. The role of the SB: SB abnormal before treatment, 10 patients, 8 sides normal after treatment, recovery rate 8O%; recovery rate of the control group 50 (8110), no significant difference between the two groups (x = 2.36,ugg stiefel, P> ; 0.05). 2. On A | role: Before treatment, the treatment group 14 patients with abnormal ALT, normal l0 patients after treatment, recovery rate 71.5 (1o/14) j normalization control group was 61.1% (n/1 , two groups were not statistically significant (X = 0.38, P> 0.05). 3. The role of HBVM: H ~ eAg end of treatment, negative conversion rate of treatment group was 60 (30/50), the control group was 15.8 (6/3s), there were significant differences between the two groups (x a 17.48, P < ; 0.001). HBeAg seroconversion rate in treatment group 32 (16 / ~ 0) in the control group l3 (5 / 3, two groups were significantly different (x = 4.23, P <O.05). HBgAb seroconversion rate in treatment group 44% (22,150), the control group l3.2% (5 / 8, there was a significant difference between the two groups (x = 9.65, P <O.O1). 4. HBeA ~ overcast and the relationship between the number of injections: treatment group negative rate 6O (3o / ~ 0), one injection of 5 short, patients with decompensated liver cirrhosis the presence of hypothalamic-pituitary-gonadal axis dysfunction, as serum PRL ~ |
|
